GIGAGEN
Company Snapshot
Founded: 2010
Entity Type: Private
Region: U.S.
Headquarter: California, U.S.
Key Geographics: U.S.
Corporate Address: 1 Tower Pl, Suite 750, South San Francisco, California 94080 U.S. Tel. +1-650-799-1570 www.gigagen.com
Company Overview
Founded in 2010, GigaGen develops technology for analyzing single cells that use droplet multiplex polymerase chain reaction (PCR) coupled with NGS technologies. The platform is called Cell-Seq, or massively parallel single-cell sequencing.
The target market for Cell-Seq is currently served by flow cytometry, but flow cytometry does not currently address the deeper analysis provided by NGS.
Cell-Seq allows for the ability to study the clonal expansion of different types of immune cells and to quantify which fractions of different clones are present.
The end markets for Cell-Seq include personalized diagnostics for individuals based on their particular clones.
GIGAGEN In News
Company's Business Segments
- Product : Oncology, Recombinant Polyclonal, Others
- Services : Research and Development, Publications, Others
Applications/End User Industries
- Biotechnology
- Pharmaceutical
- Healthcare
- Oncology
- Immunology
BCC Research Beacon 